Kumar, S., Kaufman, J. L., Mikhael, J., Gasparetto, C., Vij, R., Pegourie, B., … Touzeau, C. (2018). Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma. In BRITISH JOURNAL OF HAEMATOLOGY (Vol. 181, pp. 100–101). Liverpool, ENGLAND: WILEY.

Kumar, S., J. L. Kaufman, J. Mikhael, C. Gasparetto, R. Vij, B. Pegourie, L. Benboubker, et al. “Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma.” In BRITISH JOURNAL OF HAEMATOLOGY, 181:100–101. WILEY, 2018.

Kumar S, Kaufman JL, Mikhael J, Gasparetto C, Vij R, Pegourie B, et al. Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma. In: BRITISH JOURNAL OF HAEMATOLOGY. WILEY; 2018. p. 100–1.

Kumar, S., et al. “Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma.” BRITISH JOURNAL OF HAEMATOLOGY, vol. 181, WILEY, 2018, pp. 100–01.

Kumar S, Kaufman JL, Mikhael J, Gasparetto C, Vij R, Pegourie B, Benboubker L, Facon T, Moreau P, Amiot M, Alzate S, Dunbar M, Xu T, Agarwal S, Leverson J, Ross J, Maciag P, Verdugo M, Touzeau C. Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma. BRITISH JOURNAL OF HAEMATOLOGY. WILEY; 2018. p. 100–101.